Refine by
Medidata Clinical And Operational Data Software Available In In Latvia
5 software items found
by:Medidata based inNew York, NEW YORK (USA)
Patient Cloud is a suite of powerful solutions that makes it simple and engaging for patients to participate in any clinical trial – so your trials are easier, faster, and produce better results. Built into the Medidata Clinical Cloud platform, Patient Cloud solutions combine Medidata’s leading clinical trial technology with unmatched patient centricity by design. Only Patient Cloud ...
by:Medidata based inNew York, NEW YORK (USA)
Medidata’s eConsent is an innovative, regulatory-compliant, patient-friendly, electronic consent system for clinical trials. Whether onsite or remote, Medidata eConsent automates the patient enrollment process and onboards patients directly into Rave EDC, improving overall consent tracking management, reducing informed consent errors, and easing the administrative burden for sites and study ...
by:Medidata based inNew York, NEW YORK (USA)
Medidata AI Integrated Evidence connects historical data from more than 23,000 cross-sponsor clinical trials and 7 million patient volunteers with real world data to deliver powerful insights and the necessary evidence clinical development leaders need to increase the probability of trial success. Artificial intelligence and data can help fuel new ways of working on clinical trials and beyond. ...
by:Medidata based inNew York, NEW YORK (USA)
Action Powered by Data and Advanced Analytics. Medidata is the only provider capable of taking 20+ years of data and insights and operationalizing it across the trial continuum, moving you beyond static, siloed systems, to an ecosystem providing a complete view of the patient and site experience, and unified workflows driving faster trial timelines. ...
by:Medidata based inNew York, NEW YORK (USA)
Medidata AI Synthetic Control Arm (SCA®) offers the only external control arm created with cross-industry historical clinical trial data from 25,000+ clinical trials and 7 million patients. SCA can enable scientific research, cut costs and accelerate timelines in scenarios where a control group is hard to recruit or retain, such as rare or imminently life-threatening diseases with inadequate ...